HSCT, Human Microbiome
Conditions
Keywords
Microbiome, stem cell transplantation
Brief summary
Allogenic HSCT brings significant changes in biodiversity and composition of the gut microbiome through antibiotic usage, the mucosal damage due to the chemo- and radiotherapy toxicity; compromised oral nutritional intake and graft-versus-host disease with gut damage as the complication. Aim of the study is to investigate the composition of the microbiota in both recipient and nursing relative donor, reveal changes in biodiversity after HSCT via 3-time points V3V4 16S rRNA and NGS sequencing of the colon and oral swabs, 3-indoxyl-sulfate measurement in the urine.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* indications to alloHSCT * nursing healthy donors 3-55 y.o.
Exclusion criteria
* unable to give samples for the test * graft rejection * previous HSCT
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| beta-index dynamics | 7 days before HSCT | biodiversity (beta-index) dynamics between time points before and after HSCT |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of patients with microbial domination after HSCT | 7 days after HSCT | evaluation of the dynamics of the microbial domination between time points before and after HSCT |
| Shannon-index dynamics | 7 days before HSCT | biodiversity (Shannon-index - an information statistic index, which means it assumes all species are represented in a sample and that they are randomly sampled) dynamics between time points before and after HSCT |
| ROC (receiver operating characteristic)-curve of NGS (new-generation sequence) | 7 days before HSCT | sensitivity of NGS as a method of biodiversity evaluation |
Countries
Russia